2018 State and Federal Legislative & Regulatory Priorities
Diabetes Research and Programs
- Increase overall funding dedicated to diabetes research, programs, and clinical translation of research, including, but not limited to:
- The National Institute of Diabetes and Digestive and Kidney Diseases at the National Institutes of
- The Division of Diabetes Translation at the Centers for Disease Control and Prevention.
- The Special Diabetes Program for type 1 research and programs in American Indian/Alaska Native
- The National Diabetes Prevention Program to support community-based programs to prevent type
- 2 diabetes
- Diabetes research and prevention programs in states.
- Innovative funding for diabetes research and programs.
- Protect research opportunities
Access to Adequate and Affordable Health Care
- Ensure public and private health insurance coverage options, including, but not limited to, those under the
Affordable Care Act, Medicare, Medicaid, Children’s Health Insurance Program, and state-mandated
benefits provide adequate and affordable access to the medications, tools, education, and health care
necessary to meet the Association’s Standards of Medical Care in Diabetes.
- Oppose weakening of existing protections for people with diabetes and prediabetes in federal and state
- Make insulin affordable for all who need it and increase transparency throughout the insulin supply chain.
- Assess the burden of diabetes and prediabetes to develop, implement, and promote diabetes prevention policies and programs.
- Reduce obesity, improve nutrition, and increase physical activity in communities.
- Ensure students with diabetes are medically safe and have access to the same educational opportunities as peers without diabetes.
- Ensure laws and policies for private and commercial driver’s licenses result in fair treatment of people with diabetes.
- Ensure fair treatment of employees with diabetes.
- Ensure fair treatment of people with diabetes accessing places of public accommodation and public services.
- Promote health equity among at risk populations affected by diabetes and prediabetes.
Advancing Treatments and Technology
• Provide scientific expertise to regulators on issues related to diabetes and the need for improved means to treat, monitor, and prevent diabetes.